Apheresis is the process of removing blood from a patient while using a special machine to separate the different components of blood. One or more components are removed to use in treatments or ...

Lipoprotein apheresis involves the extracorporeal removal of LDL and lipoprotein(a) particles from whole blood or plasma by adsorption, precipitation or differential filtration. Used repetitively ...

Attendees will learn how subtle differences in the apheresis process can lead to significant discrepancies in the cellular products, ultimately affecting the efficacy of the therapies derived from ...

The global apheresis market was valued at $2.4 billion in 2021 and is projected to reach $5.3 billion by 2031, growing at a CAGR of 8.3% from 2022 to 2031.

Previous studies have suggested that leukocyte apheresis, which selectively removes about 65% of activated granulocytes and 55% of activated monocytes from peripheral blood, can improve IBD ...

The sale to GVS is expected to enhance the company’s focus on its core apheresis solutions, which constitute a significant portion of its blood center business and possess a more promising growth ...